Lexicon Pharmaceuticals (LXRX) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.22
-0.2
-0.18
-0.16

Details

Expected EPS
-0.162843
Actual EPS
-0.18
Surprise EPS
-0.02
Surprise Percent
+10.54%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.18 per share for Q4 2024.

0 Comments

Share your thoughts